These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 15705254

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C, Elliott PM.
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract] [Full Text] [Related]

  • 3. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ.
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract] [Full Text] [Related]

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Sudden death in hypertrophic myocardiopathy].
    Cardim N, Longo S, Gouveia D, Lousada N, Ferreira T, Pereira AT, Correia JM.
    Rev Port Cardiol; 1995 Sep; 14(9):655-9. PubMed ID: 7576766
    [Abstract] [Full Text] [Related]

  • 7. [Syncope of uncertain cause and sudden cardiac death in young patients].
    Schimpf R, Wolpert C, Veltmann C, Kuschyk J, Borggrefe M.
    Dtsch Med Wochenschr; 2006 May 05; 131(18):1040-6. PubMed ID: 16673231
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sudden death in hypertrophic cardiomyopathy.
    Watkins H.
    N Engl J Med; 2000 Feb 10; 342(6):422-4. PubMed ID: 10666434
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Device therapy in hypertrophic cardiomyopathy.
    Beadle R, Williams L.
    Expert Rev Cardiovasc Ther; 2010 Dec 10; 8(12):1767-75. PubMed ID: 21108558
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S, Spirito P, Masi AS, Chiribiri A, Bonamini R, Conte MR.
    Circ Cardiovasc Imaging; 2009 Jul 10; 2(4):349-50. PubMed ID: 19808616
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ, Towbin JA, Denfield SW.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):250-4. PubMed ID: 19589438
    [Abstract] [Full Text] [Related]

  • 16. Implantable defibrillators in hypertrophic cardiomyopathy.
    Grace A.
    Heart; 2009 May 14; 95(9):695-6. PubMed ID: 19282312
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ.
    Rev Esp Cardiol; 2006 Jun 14; 59(6):527-30. PubMed ID: 16790193
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M, Czarnecka D, Bacior B, Petkow-Dimitrow P, Wilczek R, Kawecka-Jaszcz K.
    Kardiol Pol; 2005 Aug 14; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [Abstract] [Full Text] [Related]

  • 20. Risk assessment in hypertrophic cardiomyopathy.
    Saumarez RC.
    Heart; 2009 Mar 14; 95(5):421; author reply 421. PubMed ID: 19218265
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.